[Enhanced drug hydroxylation in man under diphenyl-hydantoin therapy].
D000284:Administration, Oral; D000983:Antipyrine / Q000097:blood / Q000378:metabolism* / Q000652:urine; D001673:Biodegradation, Environmental; D003404:Creatinine / Q000652:urine; D004827:Epilepsy / Q000188:drug therapy*; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy / Q000201:enzymology; D006207:Half-Life; D006801:Humans; D006900:Hydroxylation; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism; D010672:Phenytoin / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D013268:Stimulation, Chemical
D010672:Phenytoin; D003404:Creatinine; D000983:Antipyrine
Gesteigerte Hydroxylierung von Arzneimitteln beim Menschen unter Diphenylhydantoinbehandlung